Mirum Pharmaceuticals, Inc. (MIRM) Net income 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$23.4MFY2025 · since FY2019: -$52.6M → -$23.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.4M | +73.4% |
| FY2024 | -$87.9M | +46.2% |
| FY2023 | -$163.4M | -20.5% |
| FY2022 | -$135.7M | -61.5% |
| FY2021 | -$84.0M | +18.7% |
| FY2020 | -$103.3M | -96.5% |
| FY2019 | -$52.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice